TMPRSS13 and lung carcinoma: The active form of TMPRSS13 is expressed in human lung as well as nasal tissue, and siRNA-mediated knockdown of TMPRSS13 in Calu-3 human lung cancer cells resulted in a significant reduction in SARS-CoV-2 replication (38).